Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: bioengineering – Page 86

𝐌𝐞𝐝𝐢𝐜𝐚𝐥𝐗𝐩𝐫𝐞𝐬𝐬:

The Neuro-Network.

𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐢𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐞 𝐢𝐧𝐭𝐨 𝐡𝐮𝐦𝐚𝐧 𝐜𝐞𝐥𝐥𝐬 𝐚 𝐠𝐞𝐧𝐞𝐭𝐢𝐜 𝐦𝐮𝐭𝐚𝐭𝐢𝐨𝐧 𝐭𝐡𝐚𝐭 𝐩𝐫𝐨𝐭𝐞𝐜𝐭𝐬 𝐚𝐠𝐚𝐢𝐧𝐬𝐭 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫’𝐬 𝐝𝐢𝐬𝐞𝐚𝐬𝐞

𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝𝙚𝙧𝙨 𝙛𝙧𝙤𝙢 𝙩𝙝𝙚 𝙐𝙣𝙞𝙫𝙚𝙧𝙨𝙞𝙩𝙚́ 𝙇𝙖𝙫𝙖𝙡 𝙁𝙖𝙘𝙪𝙡𝙩𝙮 𝙤𝙛 𝙈𝙚𝙙𝙞𝙘𝙞𝙣𝙚 𝙖… See more.

Researchers from the Université Laval Faculty of Medicine and CHU de Québec–Université Laval Research Center have successfully edited the genome of human cells grown in vitro to introduce a mutation providing protection against Alzheimer’s disease. The details of this breakthrough were recently published in The CRISPR Journal.

“Some increase the risk of developing Alzheimer’s disease, but there is a mutation that reduces this risk,” says lead author Professor Jacques-P. Tremblay. “This is a rare mutation identified in 2012 in the Icelandic population. The mutation has no known disadvantage for those who carry it and reduces the risk of developing Alzheimer’s disease. Using an improved version of the CRISPR gene editing tool, we have been able to edit the genome of human cells to insert this mutation.”

Continue reading “Researchers introduce into human cells a genetic mutation that protects against Alzheimer’s disease” | >

Not science, apparentlyLast month, a Ph.D. student at the Hebrew University of Jerusalem breed a new strain of ‘supercharged’ lettuce that expanded its vitamin C and beta carotene content by 800 percent and 70 percent respectively.

Research Interests.

Genomic/metabolomic/proteomic approaches for identification of novel (regulatory and biosynthetic) aroma genes.

Metabolic engineering of plants and yeast.

Site-specific genome modification and genetic engineering in plants.

Read more | >

A cloud-based repository that creates a digital fingerprint of engineered microorganisms has been successfully trialed.

An international team led by Newcastle University has launched CellRepo, a species and strain database that uses cell barcodes to monitor and track engineered organisms. Reported in a new study in the journal Nature Communications, the database keeps track and organizes the digital data produced during cell engineering. It also molecularly links that data to the associated living samples.

Available globally, this resource supports and has significant safety advantages, such as limiting the impact of deliberately or accidentally released genetically modified microorganisms by enabling faster tracing of organisms lab of origin and design details.

Read more | >

Dr. Marvin Minsky — A.I. Pioneer & Mind Theorist. Professor of Media Arts and Sciences, MIT, Media Lab http://GF2045.com/speakers.

As soon as we understand how the human brain works, we should be able to make functional copies of our minds out of other materials. Given that everything is made of atoms, if you make a machine, in some sense it is made of the same kinds of materials as brains are made but organized either in very different ways or fundamentally the same ways.

Interestingly, if you are going to copy the organization of a particular human mind maybe you should make a dozen of them. There is no particular limit on how many copies to make and how the future society will treat them.

When will all these great things happen of overcoming death and making people more intelligent and turning ourselves into machines with replaceable parts so that suffering will disappear? Many great science fiction writers have written well about the future of human minds and what will happen if we eliminate death and people can live forever and we keep growing and so forth.

In my view, as we still do not know very much about how exactly the brain represents knowledge and does reasoning, it is very hard to predict how long it will take to do things like that. I however am fairly confident that, sooner or later, we will. Given that, in all likelihood, it does not require the breaking of any known rules of physics, and while it clearly represents a formidable science and engineering challenge, it is not a matter of “if” but a matter of “when” — it is a matter of time.

For more information about the GF2045 congress, please visit http://www.GF2045.com

Continue reading “Dr. Marvin Minsky — Facing the Future” | >

FeaturedRead our 3 books at https://lifeboat.com/ex/books.

The Lifeboat Foundation is a nonprofit nongovernmental organization dedicated to encouraging scientific advancements while helping humanity survive existential risks and possible misuse of increasingly powerful technologies, including genetic engineering, nanotechnology, and robotics/AI, as we move towards the Singularity.

Lifeboat Foundation is pursuing a variety of options, including helping to accelerate the development of technologies to defend humanity, such as new methods to combat viruses, effective nanotechnological defensive strategies, and even self-sustaining space colonies in case the other defensive strategies fail.

We believe that, in some situations, it might be feasible to relinquish technological capacity in the public interest (for example, we are against the U.S. government posting the recipe for the 1918 flu virus on the internet). We have some of the best minds on the planet working on programs to enable our survival. We invite you to join our cause!

Visit our site at https://lifeboat.com. Participate in our programs at https://lifeboat.com/ex/programs. Follow our Twitter feed at https://twitter.com/LifeboatHQ and our GETTR feed at https://gettr.com/user/LifeboatHQ. Watch our YouTube channel at https://youtube.com/lifeboathq. Read our blog at https://lifeboat.com/blog. Join our LinkedIn group at https://www.linkedin.com/groups/35656. Subscribe to our newsletter at https://lifeboat.com/newsletter.cgi.

Interact with the author of “The Human Race to the Future: What Could Happen—and What to Do” at https://www.facebook.com/groups/thehumanracetothefuture.

Continue reading “HumanityMars NEW YEAR 2030 PARTY IN MARS CITY!” | >

“It was either die or do this transplant. I want to live. I know it’s a shot in the dark, but it’s my last choice,” said Bennett.

The heart was provided by Revivicor, a company based in Virginia that has been engineering pig organs for roughly two decades. In several experiments for pig-to-baboon transplants, the organs survived up to nine months, until the animals passed away due to a lung infection unrelated to the transplant.

Overall, the heart had 10 hefty genetic edits. Three of them wiped out sugar molecules on the outside of cells that provoke an immune response. Six bolstered the chance of the human host accepting the heart—amping up an anti-inflammatory response, preventing blood vessel damage, and dampening any antibodies against the organ. Finally, the last edit limited the pig heart’s size. Although it generally matched the size of a human heart, the team wanted to prevent the pig organ from overgrowth inside Bennett’s chest once it was transplanted—something they previously noticed happened in baboons.

Read more | >

And it took less than a full workday. Stanford Medicine scientists and their collaborators have engineered a new genome sequencing technique that can diagnose rare genetic diseases in an average of eight hours. This is a record-breaking time frame that is leap and bounds ahead of other current advanced technologies.

Gene sequencing is crucial to advancing science! Check out why cutting time and cost is key.

Read more | >

Innovating Life-Saving Therapeutic Devices — Dr. Amy Throckmorton, PhD — BioCirc Research Laboratory, Drexel University School of Biomedical Engineering, Science and Health Systems.

Dr. Amy Throckmorton, Ph.D. (https://drexel.edu/biomed/faculty/core/ThrockmortonAmy/) is Associate Professor and Director of the BioCirc Research Laboratory, in the School of Biomedical Engineering, Science and Health Systems, at Drexel University.

The BioCirc Research Laboratory seeks to improve the treatment strategies and therapeutic options for pediatric and adult patients suffering from acquired or congenital heart disease by developing unique features for inclusion in the design of blood pumps and to develop entirely new designs of blood pumps for patients with single ventricle or biventricular circulations as a bridge-to-transplant, bridge-to-recovery, or destination therapy.

Prior to this position, in the Department of Mechanical and Nuclear Engineering at the Virginia Commonwealth University, Dr. Throckmorton served as Associate Professor and previously held the chaired Qimonda Assistant Professorship.

Dr. Throckmorton received her PhD and MS in Biomedical Engineering, as well as a BS in Chemical Engineering, from the University of Virginia.

Continue reading “Dr. Amy Throckmorton, PhD — BioCirc / Drexel University — Innovating Life-Saving Therapeutic Devices” | >

I don’t know how about you… But I’m meeting cyborgs in the streets regularly. If you observe carefully you can find people with artificial legs and arms. So next time watch more carefully. Its most common seen artificial body part. On other hand there are other parts you can’t see, like artificial joints, dental implants, breast implants, pacemakers, insulin pumps and so on. We are unable to see them but they are very common. Millions people use them. Nowadays very common trend is biohacking where people implant magnets and chips to their bodies. We think our bodies are born complete but we are wrong. We can upgrade and modify them. What if we can use brain implants to be smarter, to think and focus sharper.

First real cyborg I have met was Prof. Kevin Warwick. We met in Pilsen at conference about artificial intelligence. He is known for his studies on direct interfaces between computer systems and the human nervous system, and has also done research concerning robotics.

Read more | >

One critical difference? Unlike a Mars mission’s “seven minutes of terror,” during which the entry, descent, and landing occur too fast for human operators to interfere, gene therapy delivery is completely blind. Once inside the body, the entire flight sequence rests solely on the design of the carrier “spaceship.”

In other words, for gene therapy to work efficiently, smarter carriers are imperative.

This month, a team at Harvard led by Dr. David Liu launched a new generation of molecular carriers inspired by viruses. Dubbed engineered virus-like particles (eVLPs), these bubble-like carriers can deliver CRISPR and base editing components to a myriad of organs with minimal side effects.

Read more | >